These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1147 related articles for article (PubMed ID: 10318916)

  • 21. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
    Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
    Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A yeast model system for functional analysis of beta-catenin signaling.
    Lee MS; D'Amour KA; Papkoff J
    J Cell Biol; 2002 Sep; 158(6):1067-78. PubMed ID: 12235124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.
    Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
    Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing.
    Soriano S; Kang DE; Fu M; Pestell R; Chevallier N; Zheng H; Koo EH
    J Cell Biol; 2001 Feb; 152(4):785-94. PubMed ID: 11266469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.
    Kim K; Pang KM; Evans M; Hay ED
    Mol Biol Cell; 2000 Oct; 11(10):3509-23. PubMed ID: 11029052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
    Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
    J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
    von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W
    Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of beta-catenin-mediated transactivation by cadherin derivatives.
    Sadot E; Simcha I; Shtutman M; Ben-Ze'ev A; Geiger B
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15339-44. PubMed ID: 9860970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
    Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
    Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt-independent beta-catenin transactivation in tumor development.
    Lu Z; Hunter T
    Cell Cycle; 2004 May; 3(5):571-3. PubMed ID: 15107603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1.
    Hanai J; Dhanabal M; Karumanchi SA; Albanese C; Waterman M; Chan B; Ramchandran R; Pestell R; Sukhatme VP
    J Biol Chem; 2002 May; 277(19):16464-9. PubMed ID: 11815623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.
    Sadot E; Conacci-Sorrell M; Zhurinsky J; Shnizer D; Lando Z; Zharhary D; Kam Z; Ben-Ze'ev A; Geiger B
    J Cell Sci; 2002 Jul; 115(Pt 13):2771-80. PubMed ID: 12077367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
    Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
    Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.